ArticleRisk management and healthcare policy2025
Prediction Models of Microinvasive Cervical Cancer in High-Grade Squamous Intraepithelial Lesion Treatment by Loop Electrosurgical Excision Procedure.
Article in Risk management and healthcare policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting mortality in non-traumatic intracerebral hemorrhage with glucose and lipid data.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The implementation of comprehensive microinvasive cervical cancer (MIC) risk assessment in high-grade squamous intraepithelial lesion (HSIL) patients undergoing loop electrosurgical excision procedure (LEEP) is critical to optimize treatment strategies and improve patient outcomes. Methods: From March 2017 to January 2024, a total of 3066 eligible patients with HSIL were retrospectively enrolled from two hospitals and assigned into one training cohort (n = 2084), one internal validation cohort (579) and one external testing cohort (n = 403). Four feature selection methods (Random Forest, Lasso regression, Boruta algorithm, and Extreme Gradient Boosting) were employed to identify key predictive factors from the training cohort. Then, four machine learning models were developed and evaluated using comprehensive metrics. The optimal model was visualized through interpretable techniques and operationalized as a web-based clinical decision support system for real-world implementation. Results: Six clinical predictive variables were identified, including surgical margins, endocervical curettage (ECC), TCT status, HPV status, Transformation Zone (TZ) type and Age. The optimal model demonstrated good predictive performance, achieving an area under the receiver operating characteristic curve (AUC) of 0.822 (95% CI: 0.793-0.852) in the internal validation cohort and 0.802 (95% CI: 0.730-0.874) in the external validation cohort. Conclusion: The machine learning-based model can accurately assess the risk of MIC during the treatment of HSIL with LEEP, potentially aiding in the selection of appropriate treatment and surveillance strategies in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.